Article | 2023.12.18
This interdisciplinary programme, funded by ECDC, combines lectures and practical sessions delivered by multiple host institutions in order to enhance surveillance, preparedness, and readiness to respond to outbreaks.
Document de presse | 2023.02.20
Forty years after the discovery of HIV in 1983 at the Institut Pasteur, 38.4 million people were living with the virus worldwide in 2021.[1] Only two cases of people being cured had previously been described: the Berlin patient in 2009 and the London patient in 2019. The IciStem consortium, whose members include Asier Sáez-Cirión's team at the Institut Pasteur, in collaboration with Düsseldorf...
Document de presse | 2023.03.29
As we mark World Autism Awareness Day on Sunday April 2, 2023, this year the Institut Pasteur is celebrating the 20th anniversary of the discovery of the first genes associated with autism. In 2003, this discovery offered a new perspective on the neurodevelopmental disorder; today, it highlights what still needs to be done to help those affected by autism. Scientists in international consortia...
News | 2024.07.30
Throughout this special Paris Games, we are pleased to present some of the Institut Pasteur staff who are playing a special role in this global event – whether in their capacity as an Institut Pasteur staff member, a volunteer or a sports person. We hope that these profiles will showcase the fantastic diversity of the Institut Pasteur community. This week, to mark the official opening of the...
Document de presse | 2014.09.09
Artemisinin is currently the most effective malarial treatment available. However, the recent emergence in South-East Asia of artemisinin-resistant parasites strengthens the urgent need to identify a new generation of antimalarial drugs. In this context, scientists at the Institut Pasteur and CNRS have determined the three-dimensional structure of a promising new therapeutic target for malaria:...
Document de presse | 2013.02.06
An international research partnership from Tunisia, France and the United States has demonstrated a high cure rate and remarkably few side effects in treating patients with cutaneous leishmaniasis (CL) with an antibiotic cream. CL is a parasitic disease that causes disfiguring lesions and affects 1.5 million people worldwide annually, including the socio-economically disadvantaged in the...
Document de presse | 2008.10.05
The Nobel Prize in Medicine 2008 has been awarded to Professors Françoise Barré-Sinoussi and Luc Montagnier for their discovery of the human immunodeficiency (AIDS) virus in 1983 at the Institut Pasteur, and to Prof. Harald zur Hausen for his discovery of the human papillomavirus, which is responsible for cervical cancer. Press releaseParis, october 6, 2008 “Twenty five...
Document de presse | 2016.11.08
30 million Euros of funding, 42 public and private institutions have joined forces for next generation vaccines.The ADITEC project was presented today at the European Parliament as a Success Story.Development of novel immunisation technologies, adjuvants, vectors and delivery systems, formulations and vaccination methods optimised for different age groups, 207 scientific publications, and...
Article | 2016.12.20
Please, note that Institut Pasteur has no financial ties with these institutions and that the links below are only suggestions to help you find housing and that your choice is completely open.Listed below are the contact details of various centres in Paris.Houses Center Foyer Saint Jean Eudes - 1 Rue Jean Dolent 75014 ParisDuration: Short Stay (1 day authorized)Residents: Girls /...
News | 2018.02.28
Why do we respond differently to infections or vaccines? Why are some people allergic to pollen? These are still unanswered questions in biological and medical science. The Milieu Intérieur Laboratory of Excellence coordinated at the Institut Pasteur by CNRS research director, Dr. Lluis Quintana-Murci, has recently described immune variation on a large scale within the French population. To...